Literature DB >> 15731735

[Thyroid hormone levels and thyroid dysfunction of French adults participating in the SU.VI.MAX study].

P Valeix1, C Dos Santos, K Castetbon, S Bertrais, C Cousty, S Hercberg.   

Abstract

Abnormal thyroid function has important public health consequences. However, the various degrees of thyroid dysfunction remain unsettled. The SU.VI.MAX cohort provided a unique opportunity to conduct a cross-sectional study of abnormal thyroid function in a large representative population of 11256 men and women representing the geographic distribution of the French continental adult population. Thyroid status was measured, in fasting blood samples, at baseline in 1994-1995. Serum thyrotropin (TSH) levels (abnormal < 0.4 mU/l or > or =4.0 mU/l) and free thyroxine (fT4) were both performed in duplicate on the same sample. Subjects with previous or present thyroid diseases or who were taking thyroid hormones or antithyroid drugs (n=920) were excluded (8.1%). Thus, the final study group consisted of 10346 subjects, 4121 men aged 45-60 years (mean +/-SD) (51.8+/-4.7 yrs), 2641 women aged 35-44 years (40.6+/-2.8 yrs), and 3584 women aged 45-60 years (51.4+/-4.4 yrs). Median (2.5th and 97.5th percentiles) for TSH (mU/l) were 1.52 (0.20-4.54) for men, 1.78 (0.22-5.54) for women aged 35-44 years, and 1.96 (0.22-6.80) for women aged 45-60 years. The TSH distribution of women was shifted to the right compared with men. Arithmetic mean fT4 (+/-SD) was 10.7+/-1.7 ng/l (13.8 +/-2.2 pmol/l) for men and 10.9+/-1.8 ng/l (14.0+/-2.3 pmol/l) for women. The prevalence of abnormal TSH values in men, and in women (35-44 yrs and 45-60 yrs) were TSH<0.4 mU/l 7.0%, 5.3% and 4.4%; TSH 4.0-9.9 mU/l 4.0%, 7.2% and 11.1% and TSH > or =10.0 mU/l 0.2%, 0.4% and 0.7%, respectively. Geometric mean serum TSH and arithmetic mean serum fT4 concentrations showed significant overall inter-regional differences for men and women (p<0.0001). There was also an inter-regional difference in the prevalence of thyroid dysfunction for men (p=0.003), and for the older group of women (i.e. > or =45 yrs) (p=0.04) exclusively. Over the age of 45 years, the women: men ratio for unrecognized elevated TSH levels (> or =4.0 mU/l) was 2.82, whereas it was 0.64 for low TSH levels (<0.4 mU/l). In summary, abnormal TSH values and thyroid dysfunction were more prevalent in women than men, increased with age and were significantly associated with environmental factors. A high prevalence of identified thyroid diseases in the French population was confirmed by the high number of subjects in this study with laboratory evidence of abnormal biochemical thyroid function. Further studies are needed to determine the geographical determinants of thyroid dysfunctions, especially regional differences in iodine intakes, and to assess the long-term adverse effects of biochemical thyroid dysfunction on all-cause morbidity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15731735     DOI: 10.1016/s0003-4266(04)95956-2

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  7 in total

1.  Undiagnosed thyroid dysfunction, thyroid antibodies, and iodine excretion in a Mediterranean population.

Authors:  Anna Lucas; María Teresa Julián; Ana Cantón; Conxa Castell; Roser Casamitjana; Eva María Martínez-Cáceres; María Luisa Granada
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

2.  Seafood (wild and farmed) for the elderly: contribution to the dietary intakes of iodine, selenium, DHA and vitamins B12 and D.

Authors:  J M Bourre; P Paquotte
Journal:  J Nutr Health Aging       Date:  2008-03       Impact factor: 4.075

3.  Late thyroid complications in survivors of childhood acute leukemia. An L.E.A. study.

Authors:  Claire Oudin; Pascal Auquier; Yves Bertrand; Philippe Chastagner; Justyna Kanold; Maryline Poirée; Sandrine Thouvenin; Stephane Ducassou; Dominique Plantaz; Marie-Dominique Tabone; Jean-Hugues Dalle; Virginie Gandemer; Patrick Lutz; Anne Sirvent; Virginie Villes; Vincent Barlogis; André Baruchel; Guy Leverger; Julie Berbis; Gérard Michel
Journal:  Haematologica       Date:  2016-03-11       Impact factor: 9.941

Review 4.  Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

Authors:  Goran Bjelakovic; Dimitrinka Nikolova; Lise Lotte Gluud; Rosa G Simonetti; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

5.  Reference intervals of thyroid hormones in Khartoum, Sudan.

Authors:  Imad R Musa; Nagi I Ali; Sittana A Elseed; Osman E Osman; Ishag Adam
Journal:  BMC Res Notes       Date:  2018-10-12

6.  A Thyroid Stimulating Hormone Reference Range: Iranian Thyroid Cohort study.

Authors:  Rokhsareh Meamar; Awat Feizi; Ashraf Aminorroaya; Massoud Amini; Maryam Nasri; Azamosadat Tabatabaei; Majid Abyar
Journal:  Acta Biomed       Date:  2021-11-03

7.  An observational study of the initial management of hypothyroidism in France: the ORCHIDÉE study.

Authors:  Brigitte Delemer; Jean-Pierre Aubert; Pierre Nys; Frédéric Landron; Stéphane Bouée
Journal:  Eur J Endocrinol       Date:  2012-10-03       Impact factor: 6.664

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.